PECONDLE® (picankibart injection) is approved by the NMPA of China for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy. Currently, ...

Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri ...

ClearSolutions Dermatology is excited to announce the opening of its new office in East Brunswick, marking a significant ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...

Your skin is in a constant state of reinvention. Every month, your body sheds and regenerates its entire outer layer—a ...

Routine testing for latent tuberculosis infection is not required for patients receiving interleukin-17 or -23 inhibitors for psoriasis, according to an updated position statement. “When IL-17 and ...

A potential for cumulative life course impairment is not completely considered in clinical practice, driving the ...